Jing Xu

机构：Jiangsu University, Affiliated Hospital of Jiangsu University, Huangshi Central Hospital · ORCID：0000-0003-4590-2924

发表论文 59 篇 · 总被引 631 次 · h-index 14

代表论文

• Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners (2023 · Cell Metabolism · 被引 53)
• CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma (2024 · Cancer Letters · 被引 36)
• Macrophage-derived VEGF-C reduces cardiac inflammation and prevents heart dysfunction in CVB3-induced viral myocarditis via remodeling cardiac lymphatic vessels (2024 · International Immunopharmacology · 被引 18)
• Nootkatone attenuates airway inflammation in asthmatic mice through repressing ROS-induced NLRP3 inflammasome activation (2023 · Biochemistry and Cell Biology · 被引 12)
• Pinosylvin Inhibits Inflammatory and Osteoclastogenesis via NLRP3 Inflammasome (2025 · Advanced Science · 被引 10)
• Hypomethylation-enhanced CRTC2 expression drives malignant phenotypes and primary resistance to immunotherapy in hepatocellular carcinoma (2024 · iScience · 被引 7)